Medical and precision equipment company DRTec saw its shares rise by more than 25% on the first day of trading after completing a stock consolidation.
As of 9:33 a.m. on September 10, DRTec's stock was trading at 6,170 won, up 29.58% (1,380 won), according to the Korea Exchange.
DRTec, listed on the KOSDAQ, manufactures digital X-ray and medical diagnostic imaging equipment, supplying diagnostic and surgical imaging solutions to domestic and international medical institutions and global companies.
The company recently received U.S. Food and Drug Administration (FDA) certification for its orthopedic surgical X-ray device, 'Extron6,' which has opened new export opportunities.
In the first half of this year, DRTec reported sales of 68.9 billion won, a 17% increase compared to the same period last year, and an operating profit of 1.3 billion won, marking a return to profitability.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.